Harlequin Strain

Harlequin is one of the original CBD-dominant cannabis strains. It was rediscovered in the early 2000s when growers began stabilizing CBD genetics, and it became the reference point for the entire high-CBD category that followed. The lineage is a four-way landrace cross — Colombian Gold, Thai, Swiss, and a Nepali indica — bred specifically to keep CBD content high while preserving the natural plant character.

The defining trait is the cannabinoid ratio. Most Harlequin cuts test at roughly 5 parts CBD to 2 parts THC. In practice, this means lab numbers usually land near 8-16% CBD against 4-7% THC. By comparison, modern high-THC flower in the regulated market routinely hits 18-30% THC with negligible CBD. Harlequin sits in a different category. The CBD competes with THC at the same receptor sites and softens the head change that defines a typical cannabis high.

Most adults describe the experience as steady. The body relaxes, stress eases, mood lifts a notch, and mental clarity stays largely intact. There is usually a small THC signal — a mild warmth or subtle mood shift — but it is not the cognitive shift most people associate with cannabis. This is why Harlequin shows up so often in conversations about daytime cannabis use, work-friendly cannabis, and balanced flower.

Harlequin is also one of the strains that proves a simple point: cannabinoid percentages matter more than indica-or-sativa labels. Two strains can both be sativa-dominant and feel completely different if the cannabinoid ratios differ. The 5:2 CBD:THC math is what shapes the Harlequin experience more than the 75/25 sativa-indica split.

Here is the honest truth about CBD-dominant strains in the NJ adult-use market: supply is inconsistent. Most licensed cultivators in NJ prioritize high-THC genetics because the average buyer asks for the highest THC number on the menu. CBD-dominant strains take longer to flower, yield less, and historically sold slower — so growers run them in smaller batches.

When CBD-dominant flower does arrive on NJ shelves, it tends to come in waves. A cultivator will run a Harlequin batch, push a few hundred eighths into the regulated supply chain, and then move on. The next wave might be ACDC, Cannatonic, or a 1:1 hybrid. Brand names you may see in the NJ market that occasionally drop CBD-rich genetics include Lemonnade, Verano, GTI, Curaleaf, and smaller boutique cultivators.

Practical advice: do not drive to a dispensary expecting Harlequin to be on the menu. Call first or check the live online menu. If Harlequin is not in stock, ask the budtender what CBD-dominant or balanced-ratio cannabis is available. There is almost always something — it just may not carry the Harlequin name.

At The Library in West Orange, the menu rotates as cultivator drops arrive. Our budtenders track which CBD-rich strains and balanced 1:1 products are on the floor, and they will steer you to the closest match for what you want to feel.